Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
enGene Holdings Inc has a consensus price target of $25.8 based on the ratings of 10 analysts. The high is $34 issued by Morgan Stanley on March 11, 2025. The low is $7 issued by UBS on February 14, 2025. The 3 most-recent analyst ratings were released by JMP Securities, Morgan Stanley, and HC Wainwright & Co. on April 29, 2025, March 11, 2025, and March 11, 2025, respectively. With an average price target of $25.67 between JMP Securities, Morgan Stanley, and HC Wainwright & Co., there's an implied 470.37% upside for enGene Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/29/2025 | Buy Now | 300% | JMP Securities | Silvan Tuerkcan46% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
03/11/2025 | Buy Now | 655.56% | Morgan Stanley | Jeffrey Hung51% | $37 → $34 | Maintains | Overweight | Get Alert |
03/11/2025 | Buy Now | 455.56% | HC Wainwright & Co. | Andres Maldonado44% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
02/18/2025 | Buy Now | 477.78% | Piper Sandler | Allison Bratzel69% | → $26 | Initiates | → Overweight | Get Alert |
02/14/2025 | Buy Now | 55.56% | UBS | Colin Bristow38% | $34 → $7 | Downgrade | Buy → Neutral | Get Alert |
12/23/2024 | Buy Now | 300% | JMP Securities | Silvan Tuerkcan46% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
12/23/2024 | Buy Now | 455.56% | HC Wainwright & Co. | Andres Maldonado44% | → $25 | Initiates | → Buy | Get Alert |
12/06/2024 | Buy Now | 300% | JMP Securities | Silvan Tuerkcan46% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
11/27/2024 | Buy Now | 411.11% | Raymond James | Sean McCutcheon11% | → $23 | Initiates | → Outperform | Get Alert |
11/18/2024 | Buy Now | 300% | JMP Securities | Silvan Tuerkcan46% | → $18 | Initiates | → Market Outperform | Get Alert |
09/24/2024 | Buy Now | 566.67% | Oppenheimer | Leland Gershell68% | $30 → $30 | Reiterates | Outperform → Outperform | Get Alert |
09/11/2024 | Buy Now | 788.89% | Morgan Stanley | Jeffrey Hung51% | $40 → $40 | Maintains | Overweight | Get Alert |
08/28/2024 | Buy Now | 566.67% | Oppenheimer | Leland Gershell68% | → $30 | Initiates | → Outperform | Get Alert |
04/22/2024 | Buy Now | 566.67% | Wells Fargo | Yanan Zhu40% | → $30 | Initiates | → Overweight | Get Alert |
04/15/2024 | Buy Now | 655.56% | Guggenheim | Manuel Navas36% | → $34 | Initiates | → Buy | Get Alert |
03/28/2024 | Buy Now | 722.22% | UBS | Colin Bristow38% | → $37 | Initiates | → Buy | Get Alert |
03/08/2024 | Buy Now | 788.89% | Morgan Stanley | Jeffrey Hung51% | → $40 | Initiates | → Overweight | Get Alert |
02/20/2024 | Buy Now | 588.89% | Leerink Partners | Mani Foroohar47% | → $31 | Initiates | → Outperform | Get Alert |
The latest price target for enGene Holdings (NASDAQ:ENGN) was reported by JMP Securities on April 29, 2025. The analyst firm set a price target for $18.00 expecting ENGN to rise to within 12 months (a possible 300.00% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for enGene Holdings (NASDAQ:ENGN) was provided by JMP Securities, and enGene Holdings reiterated their market outperform rating.
There is no last upgrade for enGene Holdings
The last downgrade for enGene Holdings Inc happened on February 14, 2025 when UBS changed their price target from $34 to $7 for enGene Holdings Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of enGene Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for enGene Holdings was filed on April 29, 2025 so you should expect the next rating to be made available sometime around April 29, 2026.
While ratings are subjective and will change, the latest enGene Holdings (ENGN) rating was a reiterated with a price target of $18.00 to $18.00. The current price enGene Holdings (ENGN) is trading at is $4.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.